Workflow
博拓生物8月25日获融资买入2334.43万元,融资余额1.90亿元

Group 1 - On August 25, Botao Bio's stock increased by 0.15% with a trading volume of 201 million yuan [1] - The financing data shows that on the same day, Botao Bio had a financing purchase amount of 23.34 million yuan and a financing repayment of 26.15 million yuan, resulting in a net financing buy of -2.81 million yuan [1] - As of August 25, the total balance of margin trading for Botao Bio was 190 million yuan, which accounts for 3.11% of its circulating market value, indicating a high level compared to the past year [1] Group 2 - As of March 31, the number of shareholders for Botao Bio was 6,212, a decrease of 2.11% from the previous period [2] - For the first quarter of 2025, Botao Bio reported an operating income of 87.89 million yuan, a year-on-year decrease of 35.20%, and a net profit attributable to shareholders of 8.73 million yuan, down 77.97% year-on-year [2] - Since its A-share listing, Botao Bio has distributed a total of 798 million yuan in dividends, with 478 million yuan distributed over the past three years [2]